Dysfunctional Voiding in Men: When Urgency and a Poor Stream Occur Together

Men with urinary urgency, frequency and nocturia are often presumed to have an overactive bladder. Those with a slow stream, hesitancy or incomplete emptying may be presumed to have an enlarged prostate. However, when storage and voiding symptoms occur together, the explanation may be more complicated.

Some men have true prostate or bladder-neck obstruction. Others have an underactive bladder, an overactive bladder, a urethral narrowing, or dysfunctional voiding, in which the urinary sphincter or pelvic-floor muscles fail to relax properly while the bladder is trying to empty. Several problems may also coexist.

This distinction matters. Removing prostate tissue will not necessarily correct a pelvic floor that is closing at the wrong time and an unnecessary operation can introduce bleeding, sexual side effects, scarring or urinary leakage.

What is dysfunctional voiding?

During normal urination, the bladder muscle contracts while the bladder neck, external urinary sphincter and pelvic floor relax. It is a coordinated sequence: the bladder pushes and the outlet opens.

In dysfunctional voiding, this coordination is disturbed. The external sphincter or pelvic-floor muscles remain partly contracted or repeatedly tighten during urination. The resulting functional obstruction may produce an intermittent, fluctuating or “stop–start” stream.

The International Continence Society describes dysfunctional voiding as intermittent or fluctuating urinary flow caused by inadequate or variable relaxation of the urinary sphincter during voiding in a person without a recognised neurological disorder.

Dysfunctional voiding must be distinguished from:

Benign prostatic obstruction caused by an enlarged prostate.
Primary bladder-neck obstruction, in which the bladder neck does not open adequately.
Urethral stricture disease.
Detrusor underactivity, where the bladder contraction is too weak or too brief.
Neurological detrusor–sphincter dyssynergia.
Overactive bladder or detrusor overactivity.
Chronic prostatitis or chronic pelvic-pain syndrome.
Medication-related voiding difficulty.

The symptoms alone frequently cannot identify which of these mechanisms is responsible.

What symptoms may occur?

Men may report a mixture of storage and emptying symptoms.

Overactive-bladder-type symptoms

Sudden urgency to pass urine.
Increased daytime frequency.
Waking repeatedly at night to urinate.
Urgency urinary leakage.
Passing small amounts frequently.
Bladder discomfort when trying to delay urination.

Outflow-obstruction-type symptoms

Hesitancy before the stream begins.
A weak, intermittent or spraying stream.
Straining to pass urine.
A feeling that the pelvic floor will not “let go.”
Prolonged urination.
Post-void dribbling.
A sensation of incomplete emptying.
Recurrent urinary infections or episodes of retention.

An important principle is that overactive bladder is a symptom syndrome, not proof of the underlying cause. Urgency may arise from primary detrusor overactivity, but it can also develop when the bladder works against an obstructed or poorly relaxing outlet.

Likewise, a weak stream does not automatically mean that the prostate is obstructing the bladder.

How should these symptoms be investigated?

The assessment begins with a detailed history. The duration and pattern of symptoms, previous pelvic or prostate surgery, urinary infections, pelvic pain, constipation, medication use, neurological symptoms and sexual function are all relevant.

A practical initial assessment may include:

A validated symptom questionnaire, such as the IPSS or ICIQ-MLUTS.
A three-day bladder diary recording fluid intake, voided volumes, urgency and leakage.
Urinalysis and urine culture when indicated.
Examination of the abdomen, prostate, genitalia and neurological system.
Assessment of pelvic-floor tone and the ability to relax the pelvic floor.
Uroflowmetry, preferably with an adequately full bladder.
Ultrasound measurement of the post-void residual urine.
Assessment of prostate size.
PSA testing when clinically appropriate and after informed discussion.
Kidney-function testing when retention or upper-tract risk is suspected.
Cystoscopy when urethral stricture, bladder-neck disease, haematuria or another anatomical abnormality is possible.

A low maximum urinary flow or a raised residual suggests impaired emptying, but neither finding reliably distinguishes prostate obstruction from dysfunctional voiding or a weak bladder. The European Association of Urology advises that non-invasive tests should not be treated as substitutes for pressure-flow urodynamics when a definite diagnosis of bladder outlet obstruction is required.

The role of pelvic-floor physiotherapy

In true dysfunctional voiding, the first treatment should usually be directed at improving coordinationnot immediately removing prostate tissue.

Specialist pelvic-floor physiotherapy may include:

Learning to recognise and release pelvic-floor tension.
Diaphragmatic breathing.
Relaxed, unhurried voiding.
Avoidance of abdominal straining.
Biofeedback using surface electromyography or uroflowmetry.
Treatment of pelvic pain and muscle trigger points.
Management of constipation.
Timed or double voiding when appropriate.

This is generally pelvic-floor down-training rather than routine strengthening. Repeated forceful Kegel exercises may aggravate symptoms in a man whose pelvic floor is already overactive.

The 2026 EAU guideline recommends behavioural modification and biofeedback as first-line treatment for dysfunctional voiding in younger men. The evidence is limited, but one small study reported at least a 50% symptom improvement in 83% of treated men at three months.

Can medication be tried first?

Medication is often reasonable, provided it is matched to the suspected mechanism and the response is monitored objectively.

Alpha-blockers

An alpha-blocker such as tamsulosin, alfuzosin or silodosin may reduce smooth-muscle resistance at the prostate and bladder neck. It is particularly relevant when benign prostatic obstruction or primary bladder-neck obstruction is suspected.

Possible side effects include:

Dizziness or postural hypotension.
Fatigue.
Nasal congestion.
Ejaculatory disturbance.
Reduced or absent forward ejaculation.

Alpha-blockers do not directly retrain an external sphincter or pelvic floor that is contracting during voiding. A poor response should therefore prompt reconsideration of the diagnosis rather than automatic progression to prostate surgery.

Overactive-bladder medications

An antimuscarinic medication or a beta-3 agonist may be considered when urgency, frequency or urgency incontinence remains troublesome.

Antimuscarinic side effects may include dry mouth, constipation, blurred vision and cognitive adverse effects in susceptible patients. Beta-3 agonists may cause hypertension, headache or palpitations in some patients.

These medicines can be used cautiously in appropriately selected men with coexisting outlet symptoms, but baseline and follow-up residual urine measurements are advisable when emptying is impaired. A marked residual, weak bladder contraction or previous retention increases the importance of careful monitoring.

The EAU guideline supports adding a beta-3 agonist to an alpha-blocker when storage symptoms persist, although the average additional benefit is modest.

Other prostate medications

A 5-alpha-reductase inhibitor, such as finasteride or dutasteride, is useful only when genuine prostate enlargement and a risk of progression are present. It does not treat dysfunctional sphincter relaxation.

Daily tadalafil may improve male lower urinary tract symptoms and erectile function in selected men, although its effect on urinary flow is usually modest.

When are urodynamic studies important?

Urodynamics become particularly valuable when the symptoms and non-invasive tests tell different stories, when medication has failed, or when an irreversible operation is being considered.

A pressure-flow study assesses:

Bladder sensation during filling.
Detrusor overactivity.
Bladder compliance.
The strength of the bladder contraction.
Urinary flow in relation to bladder pressure.
Whether high-pressure, low-flow voiding confirms obstruction.
Whether low-pressure, low-flow voiding suggests detrusor underactivity.
Residual urine after voiding.

Adding pelvic-floor electromyography can demonstrate inappropriate external-sphincter activity. Videourodynamics can show where the obstruction occurs while pressure and flow are measured simultaneously.

Videourodynamics is regarded as the most informative investigation for distinguishing primary bladder-neck obstruction from dysfunctional voiding in younger men. The 2026 EAU guideline recommends videourodynamics, or standard urodynamics combined with voiding cystourethrography, with or without electromyography when either diagnosis is suspected.

Urodynamics is not required before every treatment for uncomplicated male urinary symptoms. It is particularly useful when:

The man is young and prostate enlargement is unlikely to explain the symptoms.
Symptoms are severe but the prostate is small.
The flow pattern is intermittent or unusual.
The residual urine is persistently elevated.
There is a history of retention.
Previous prostate treatment has failed.
Detrusor underactivity is possible.
Dysfunctional voiding or primary bladder-neck obstruction is suspected.
OAB symptoms and voiding symptoms coexist.
The result would determine whether surgery, neuromodulation, medication or physiotherapy is selected.

The purpose is not simply to produce a graph. It is to answer a treatment-changing question: is the outlet anatomically obstructed, functionally closed, or is the bladder failing to generate an adequate contraction?

Should bladder-neck incision or TURP be considered?

The answer depends on what has been demonstrated.

Bladder-neck incision

A bladder-neck incision may be considered when videourodynamics confirms primary bladder-neck obstruction and an adequate trial of an alpha-blocker has failed or has caused unacceptable adverse effects.

The procedure divides restricting bladder-neck fibres without removing a large amount of prostate tissue. A single, ejaculation-preserving incision may be considered in appropriately selected younger men.

Potential adverse effects include:

Bleeding or infection.
Temporary urgency, frequency and discomfort.
Temporary difficulty urinating or catheter dependence.
Retrograde or reduced-volume ejaculation.
Rare erectile or continence problems.
Bladder-neck scarring or recurrent obstruction.
Need for further treatment.

Across heterogeneous studies, the EAU guideline reports ejaculatory dysfunction rates ranging widely according to technique. Its pooled estimate was approximately 3% after bladder-neck incision, with lower reported rates after a single incision than after bilateral incisions. Fertility and ejaculatory priorities should always be discussed before surgery.

A bladder-neck incision is not the usual treatment for dysfunctional voiding at the external sphincter or pelvic floor.

TURP

A TURP removes obstructing prostate tissue and remains an effective operation for confirmed benign prostatic obstruction, particularly in men with a prostate in the conventional 30–80 mL range.

It may be reasonable when there is convincing evidence of prostatic obstruction, especially with:

Recurrent retention.
Recurrent infection caused by poor emptying.
Bladder stones.
Renal consequences of obstruction.
Persistent significant symptoms despite appropriate medication.
High-pressure obstruction demonstrated on urodynamics.

TURP should be approached cautiously when urodynamics shows no prostate obstruction. If the main problem is dysfunctional sphincter closure or a weak bladder, TURP may fail to improve the stream, urgency or residual urine.

What are the possible side effects of disobstruction surgery?

Short-term effects can include:

Burning and frequency while the prostate or bladder neck heals.
Visible blood in the urine.
Clot retention.
Urinary infection.
Temporary inability to urinate.
A temporary increase in urgency or urgency leakage.
Catheter-related discomfort.
Bleeding requiring readmission or, less commonly, transfusion.

Longer-term effects may include:

Retrograde ejaculation.
Persistent urgency or urgency incontinence.
Urethral stricture.
Bladder-neck contracture.
Recurrent obstruction or need for another procedure.
Persistent incomplete emptying when detrusor underactivity is present.
Rare persistent stress urinary incontinence.
Possible changes in erectile or orgasmic function.

Retrograde ejaculation is common after conventional TURP, affecting approximately 65–75% of men in contemporary patient-information estimates. It is not dangerous, but it changes the experience of ejaculation and can impair fertility.

What is the risk of urinary incontinence?

Urinary control may temporarily worsen after TURP or bladder-neck surgery because:

The bladder has become overactive from longstanding obstruction.
Postoperative inflammation produces urgency.
The bladder suddenly encounters much less outlet resistance.
The urinary sphincter needs time to adapt.
Pre-existing detrusor overactivity remains after the obstruction is relieved.

Early urgency and occasional leakage are therefore more common than permanent sphincter damage. Historical research suggests that some incontinence may occur initially after TURP, while persistent incontinence at approximately 12 months is around 1% in conventional series. Reported rates vary according to the definition used, the procedure, pre-existing bladder dysfunction and the characteristics of the patient.

Persistent leakage may be:

Urgency incontinence, caused by ongoing detrusor overactivity.
Stress incontinence, caused by sphincter weakness or injury.
Overflow leakage, caused by inadequate bladder emptying.
A mixture of these mechanisms.

These types require different treatment. Persistent leakage should therefore be investigated rather than simply labelled “postoperative incontinence.”

Men with preoperative urgency, demonstrable detrusor overactivity, poor bladder compliance, previous pelvic surgery, neurological disease or sphincter weakness require individualised counselling. Surgery may relieve the obstruction without curing the bladder dysfunction that developed alongside it.

Where does sacro-neuromodulation fit?

Sacro-neuromodulation uses a small implanted system to stimulate the sacral nerves involved in bladder sensation, storage, emptying and pelvic-floor coordination. Treatment starts with a temporary test phase. A permanent battery is implanted only if the test produces worthwhile improvement.

Sacral neuromodulation is an established option for appropriately selected patients with:

Refractory urgency-frequency syndrome.
Refractory urgency urinary incontinence.
Non-obstructive urinary retention.

It may be particularly attractive when a man has both storage and emptying dysfunction without a surgically correctable obstruction. It may also be considered in selected patients with detrusor underactivity after obstruction has been excluded.

Potential benefits include:

Reduced urgency and leakage.
Improved voiding.
Lower residual urine.
Reduced need for intermittent catheterisation.
A reversible test phase before permanent implantation.

Potential disadvantages include:

Failure of the test phase.
Pain at the implant or lead site.
Infection.
Lead movement or loss of benefit.
Unpleasant stimulation.
Need for reprogramming.
Battery replacement or revision surgery.
Device removal in some patients.

Published long-term studies report clinically meaningful benefit in many implanted patients with refractory OAB or non-obstructive retention. However, outcomes from predominantly female or mixed study populations should not be assumed to apply equally to every man.

Importantly, the evidence for sacral neuromodulation specifically for male dysfunctional voiding remains limited. The 2026 EAU male LUTS guideline describes it as experimental for this particular indication and recommends using the test phase to identify whether an individual is likely to benefit.

Sacral neuromodulation should not be used as a substitute for relieving proven high-pressure anatomical obstruction.

A practical treatment pathway

A sensible approach is:

Confirm the symptom pattern with a history, examination, questionnaire and bladder diary.
Exclude infection, haematuria, urethral stricture, neurological disease and medication-related causes.
Measure urinary flow and post-void residual urine.
Assess prostate size and perform cystoscopy when anatomy needs clarification.
Begin conservative treatment, including fluid and bowel management and pelvic-floor relaxation.
Trial an alpha-blocker when bladder-neck or prostatic resistance is possible.
Add carefully selected OAB medication when storage symptoms persist, with residual monitoring where appropriate.
Use pressure-flow urodynamics, ideally with video and pelvic-floor EMG, when the diagnosis remains uncertain or surgery is contemplated.
Reserve bladder-neck incision for demonstrated primary bladder-neck obstruction.
Reserve TURP or another prostate disobstruction procedure for demonstrated or strongly supported benign prostatic obstruction.
Consider sacral neuromodulation for refractory OAB or non-obstructive retention after correctable obstruction has been excluded.
Use intermittent self-catheterisation when emptying remains unsafe or inadequate despite other treatment.

The key message

In men with urgency and a poor stream, the most important question is not simply, “Is the prostate enlarged?” It is, “What are the bladder and outlet doing during urination?”

Dysfunctional voiding, primary bladder-neck obstruction, benign prostatic obstruction, detrusor overactivity and detrusor underactivity can produce remarkably similar symptoms. Treatment is most successful when it is directed at the demonstrated mechanism.

Pelvic-floor relaxation and biofeedback are appropriate first-line treatments for dysfunctional voiding. Alpha-blockers may help bladder-neck or prostatic resistance. OAB medicines can be added carefully when storage symptoms remain troublesome. Urodynamics can prevent an inappropriate disobstruction procedure in an uncertain case. Bladder-neck incision or TURP should be used for confirmed obstructionnot simply because the stream is poor. Sacral neuromodulation may be valuable for selected refractory patients, but its role specifically in male dysfunctional voiding is still evolving.

So, if you are in this unfortunate situation and you need help, come see your Brisbane functional urologist, dr Jo Schoeman for advice.

References and further reading

European Association of Urology. EAU Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms, 2026. Full guideline
European Association of Urology. Diagnostic evaluation of male LUTS. EAU diagnostic chapter
European Association of Urology. Disease management of male LUTS, including voiding dysfunction in younger men. EAU treatment chapter
International Continence Society. Dysfunctional voiding during male pressure-flow studies. ICS terminology resource
Cameron AP, et al. The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. Journal of Urology. 2024. PubMed record
Creta M, et al. Management of Primary Bladder Neck Obstruction and Dysfunctional Voiding in Young Men: A Systematic Review and Meta-analysis. European Urology Focus. 2025. PubMed record
Drake MJ, et al. Diagnostic Assessment of Lower Urinary Tract Symptoms in Men Considering Prostate Surgery: The UPSTREAM Randomised Controlled Trial. European Urology. 2020;78:701–710. PubMed record
D’Ancona C, et al. The International Continence Society report on terminology for adult male lower urinary tract and pelvic-floor symptoms and dysfunction. Neurourology and Urodynamics. 2019;38:433–477. PubMed record
British Association of Urological Surgeons. TURP for benign disease: patient information. BAUS information page
Jairam R, et al. Predictive factors in sacral neuromodulation: a systematic review. Urologia Internationalis. 2022;106:323–342. Open-access review

This article provides general information and does not replace individual assessment. Medication and procedural decisions should be based on the patient’s examination, prostate and bladder anatomy, residual urine, urodynamic findings, comorbidities, fertility priorities and personal treatment goals.

Dysfunctional Voiding in Men: When Urgency and a Poor Stream Occur Together

What is dysfunctional voiding?